Cargando…

The T-Cell Response to SARS-CoV-2 Vaccination in Inflammatory Bowel Disease is Augmented with Anti-TNF Therapy

Detalles Bibliográficos
Autores principales:	Li, Dalin, Xu, Alexander, Mengesha, Emebet, Elyanow, Rebecca, Gittelman, Rachel M, Chapman, Heidi, Prostko, John C, Frias, Edwin C, Stewart, James L, Pozdnyakova, Valeriya, Debbas, Philip, Mujukian, Angela, Horizon, Arash A, Merin, Noah, Joung, Sandy, Botwin, Gregory J, Sobhani, Kimia, Figueiredo, Jane C, Cheng, Susan, Kaplan, Ian M, McGovern, Dermot P B, Merchant, Akil, Melmed, Gil Y, Braun, Jonathan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Basic Brief Science Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047232/ https://www.ncbi.nlm.nih.gov/pubmed/35397000 http://dx.doi.org/10.1093/ibd/izac071

Ejemplares similares

The T-cell clonal response to SARS-CoV-2 vaccination in inflammatory bowel disease patients is augmented by anti-TNF therapy and often deficient in antibody-responders
por: Li, Dalin, et al.
Publicado: (2021)

Differences in SARS-CoV-2 Vaccine Response Dynamics Between Class-I- and Class-II-Specific T-Cell Receptors in Inflammatory Bowel Disease
por: Xu, Alexander M., et al.
Publicado: (2022)

1165: SARS-COV-2 VACCINATION INDUCES A PREDOMINENTLY CLASS II (CYTOKINE EFFECTOR) T CELL RESPONSE, BUT THE CLASS I RESPONSE IS AUGMENTED BY ANTI-TNF THERAPY AND VACCINE TYPE
por: Xu, Alexander, et al.
Publicado: (2022)

Mo1018: THE T-CELL RESPONSE TO SARS-COV-2 VACCINATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE IS OFTEN DEFICIENT IN ANTIBODY-RESPONDERS, AND AUGMENTED BY ANTI-TNF THERAPY
por: Li, Dalin, et al.
Publicado: (2022)

Postvaccination Symptoms After a Third Dose of mRNA SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease: Results From CORALE-IBD
por: Li, Dalin, et al.
Publicado: (2022)

Longitudinal SARS-CoV-2 mRNA Vaccine-Induced Humoral Immune Responses in Patients with Cancer
por: Figueiredo, Jane C., et al.
Publicado: (2021)

Post-Vaccination Symptoms after A Third Dose of mRNA SARS-CoV-2 Vaccination in Patients with Inflammatory Bowel Disease
por: Li, Dalin, et al.
Publicado: (2021)

Decreased Antibody Responses to Ad26.COV2.S Relative to SARS-CoV-2 mRNA Vaccines in Patients With Inflammatory Bowel Disease
por: Pozdnyakova, VALERIYA, et al.
Publicado: (2021)

Symptomology following mRNA vaccination against SARS-CoV-2
por: Ebinger, Joseph E., et al.
Publicado: (2021)

653: PATIENTS WITH INFLAMMATORY BOWEL DISEASE HAVE IMPAIRED HUMORAL BUT PRESERVED CELLULAR RESPONSES TO SARS-COV-2 MRNA VACCINATION
por: Li, Dalin, et al.
Publicado: (2022)

Awareness of SARS-CoV-2 Omicron Variant Infection Among Adults With Recent COVID-19 Seropositivity
por: Joung, Sandy Y., et al.
Publicado: (2022)

Reply
por: Melmed, Gil, et al.
Publicado: (2021)

A Paratope-Enhanced Method to Determine Breadth and Depth TCR Clonal Metrics of the Private Human T-Cell Vaccine Response after SARS-CoV-2 Vaccination
por: Li, Dalin, et al.
Publicado: (2023)

Winter Is Coming! Clinical, Immunologic, and Practical Considerations for Vaccinating Patients With Inflammatory Bowel Disease During the Coronavirus Disease-2019 Pandemic
por: Melmed, Gil Y., et al.
Publicado: (2021)

656: POST-VACCINATION SYMPTOMS AFTER A THIRD DOSE OF SARS-COV-2 MRNA VACCINATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
por: Mujukian, Angela, et al.
Publicado: (2022)

Demographic and clinical characteristics associated with variations in antibody response to BNT162b2 COVID-19 vaccination among healthcare workers at an academic medical centre: a longitudinal cohort analysis
por: Ebinger, Joseph E, et al.
Publicado: (2022)

Seroprevalence of antibodies to SARS-CoV-2 in healthcare workers: a cross-sectional study
por: Ebinger, Joseph E, et al.
Publicado: (2021)

SARS-CoV-2 vaccination for patients with inflammatory bowel diseases: recommendations from an international consensus meeting
por: Siegel, Corey A, et al.
Publicado: (2021)

Relationship between the gut and the spine: a pilot study of first-degree relatives of patients with ankylosing spondylitis
por: Kehl, Amy S, et al.
Publicado: (2017)

Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2
por: Ebinger, Joseph E., et al.
Publicado: (2021)

Reduced expression of COVID-19 host receptor, ACE2 is associated with small bowel inflammation, more severe disease, and response to anti-TNF therapy in Crohn’s disease
por: Potdar, Alka A., et al.
Publicado: (2020)

Profiling the inflammatory bowel diseases using genetics, serum biomarkers, and smoking information
por: Liu, Ruize, et al.
Publicado: (2023)

Genetic associations with adverse events from anti-tumor necrosis factor therapy in inflammatory bowel disease patients
por: Lew, Daniel, et al.
Publicado: (2017)

SARS-CoV-2 vaccine uptake, perspectives, and adverse reactions following vaccination in patients with cancer undergoing treatment
por: Figueiredo, J.C., et al.
Publicado: (2022)

Altered Intestinal ACE2 Levels Are Associated With Inflammation, Severe Disease, and Response to Anti-Cytokine Therapy in Inflammatory Bowel Disease
por: Potdar, Alka A., et al.
Publicado: (2021)

Sparse generalized linear model with L(0) approximation for feature selection and prediction with big omics data
por: Liu, Zhenqiu, et al.
Publicado: (2017)

Review of Immunologic Manifestations of COVID-19 Infection and Vaccination
por: Pozdnyakova, Valeriya, et al.
Publicado: (2022)

Review of Immunologic Manifestations of COVID-19 Infection and Vaccination
por: Pozdnyakova, Valeriya, et al.
Publicado: (2023)

Crohn’s disease in endoscopic remission, obesity, and cases of high genetic risk demonstrates overlapping shifts in the colonic mucosal-luminal interface microbiome
por: Jacobs, Jonathan P., et al.
Publicado: (2022)

Cancer Screening Practices Among Healthcare Workers During the COVID-19 Pandemic
por: Datta, Geetanjali D., et al.
Publicado: (2022)

Evidence of premature lymphocyte aging in people with low anti-spike antibody levels after BNT162b2 vaccination
por: Huang, Yapei, et al.
Publicado: (2022)

Association of NOD2 and IL23R with Inflammatory Bowel Disease in Puerto Rico
por: Ballester, Veroushka, et al.
Publicado: (2014)

Self-Renewal of Acute Lymphocytic Leukemia Cells Is Limited by the Hedgehog Pathway Inhibitors Cyclopamine and IPI-926
por: Lin, Tara L., et al.
Publicado: (2010)

P5 A Cut Throat approach to post thyroidectomy care
por: McGovern, J, et al.
Publicado: (2021)

Paradoxical sex-specific patterns of autoantibody response to SARS-CoV-2 infection
por: Liu, Yunxian, et al.
Publicado: (2021)

An Exploration of the Psycho-Social Benefits of Providing Sponsorship and Supporting Others in Traditional 12 Step, Self-Help Groups
por: McGovern, William, et al.
Publicado: (2021)

Exposure to PM 2.5 and Birth Outcomes: Evidence from a Population-wide Database.
por: Rowland, Neil, et al.
Publicado: (2022)

Is Long-Term Exposure to Ambient Air Pollution a Risk Factor for Parkinson’s Disease.
por: Jahanshahi, Babak, et al.
Publicado: (2022)

Long-term Exposure to Ambient PM2.5 and Self-Reported Health: Evidence from Longitudinally-linked Census Data.
por: Rowland, Neil, et al.
Publicado: (2022)

The rise of depression and the risk of suicide: Understanding dysphoria in modern society
por: Overholser, J, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_a64jgbmeb3tqh3aiqrriao0alc